Articles tagged "Kidney transplantation"

2019 American Transplant Congress
Long-Term Outcomes of Older Kidney-Transplant Recipients: A Single-Center Experience
S. Sultan, M. Aull, M. Lubetzky, A. Watkins, S. Kapur
Weill Cornell Medical College, New York, NY
*Purpose: Given the aging population of patients with ESRD, and the high rates of associated mortality, at our center we perform an individualized risk assessment…
2019 American Transplant Congress
Tandem Mass Tags Based Liquid Chromatography/ Mass Spectrometry Analysis of Quantitative Proteomic Changes in Renal Allograft Biopsies with Polyomavirus BK Nephropathy
F. Fang, P. Liu, L. Song, Y. Zhao, G. Zeng, G. Tseng, K. Xiao, P. Randhawa
University of Pittsburgh, Pittsburgh, PA
*Purpose: Transcriptomics analyses have not generated reliable means to distinguish T-cell mediated rejection (TCMR) from BK virus nephropathy (BKVN). Proteomics-based approaches deserve further exploration since…
2019 American Transplant Congress
Single-Port Robotic Kidney Transplantation: Initial Pre-Clinical Experience Using the SP Surgical System
M. Eltemamy, J. Garisto, R. Bertolo, E. Miller, A. Wee, J. Kaouk
Cleveland Clinic, Cleveland, OH
*Purpose: Multiport robotic kidney transplantation has been described as a novel minimally invasive approach. We evaluate the feasibility of a robot-assisted single-port kidney transplantation using…
2019 American Transplant Congress
Infectious Complications after Treatment of Antibody-Mediated Kidney Allograft Rejection: A National Cohort Study
N. Perrottet¹, D. Golshayan², O. Manuel², V. Aubert², M. Koller³, K. Hadaya⁴, L. Bühler⁴, T. Mueller⁵, U. Huynh-Do⁶, S. Dahdal⁶, I. Binet⁷, M. Dickenmann³, S. Schaub³, J. Steiger³, M. Pascual², M. Fernández-Ruiz²
¹Pharmacy, CHUV, Lausanne, Switzerland, ²CHUV, Lausanne, Switzerland, ³USB, Basel, Switzerland, ⁴HUG, Geneva, Switzerland, ⁵USZ, Zurich, Switzerland, ⁶Inselspital, Bern, Switzerland, ⁷KSSG, St. Gallen, Switzerland
*Purpose: Multimodal therapeutic strategies used to treat acute antibody-mediated rejection (AMR) could enhance the risk of infection. However, data in this context are scarce.*Methods: We…
2019 American Transplant Congress
Lack of Linguistically and Culturally Tailored Initiatives in Kidney Transplant Programs in the United States
S. Carbunaru¹, A. Ortiz², C. Ortiz³, J. Ortiz³, J. Locke⁴, J. Caicedo¹
¹Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, ²University of California, Los Angeles, Los Angeles, CA, ³Department of Surgery, University of Toledo College of Medicine & Life Sciences, Toledo, OH, ⁴University of Alabama at Birmingham, Birmingham, AL
*Purpose: Although minorities are the majorities in the kidney transplant waiting list, it is unknown if kidney transplant programs in United States have implemented linguistically…
2019 American Transplant Congress
Specific Reasons for Public Health Service (PHS) Increased Risk (IR) Designation Had Little Influence on Doctors’ Kidney Offer Acceptance Decisions in Controlled “Lab” Experiment
D. Stewart¹, J. Rosendale¹, H. McGehee¹, J. Schold², J. Lindemans³, J. Kessler⁴, C. Sullivan⁴, K. Mekeel⁵, R. Stratta⁶, R. Formica⁷, D. Klassen¹
¹UNOS, Richmond, VA, ²CCF, Cleveland, OH, ³Duke, Durham, NC, ⁴Wharton, Philadelphia, PA, ⁵UCSD, San Diego, CA, ⁶Wake Forest, Winston-Salem, NC, ⁷Yale, New Haven, CT
*Purpose: Over 25% of donors are labeled as PHS “increased risk,” a designation associated with reduced organ utilization despite favorable risk/benefit calculations for most patients.…
2019 American Transplant Congress
Screening for Renal Cell Masses in Kidney Transplant
H. E. Fernandez, D. Tsapepas, D. J. Cohen, M. Sumit, L. E. Ratner
Columbia University MC, New York, NY
*Purpose: End-stage renal disease (ESRD) is a risk factor for development of acquired cystic kidney disease (ACKD) with the incidence of ACKD rising from 90%…
2019 American Transplant Congress
Ex Vivo Assessment of Marginal Human Kidneys Using Computed Tomography
M. K. Harris¹, J. R. DiRito², H. Liu³, N. Boutagy³, C. Liu⁴, S. Hosgood², D. Mulligan¹, M. L. Nicholson², A. Sinusas³, D. Haakinson¹, G. T. Tietjen¹
¹Surgery, Yale School of Medicine, New Haven, CT, ²Surgery, University of Cambridge, Cambridge, United Kingdom, ³Yale Translational Research Imaging Center, New Haven, CT, ⁴Radiology, Yale School of Medicine, New Haven, CT
*Purpose: Thousands of ‘marginal’ organs are discarded each year despite a severe organ shortage. This has motivated development of new technologies, such as ex vivo…
2019 American Transplant Congress
Did COIIN Cohort A Maintain Graft Survival Performance While Increasing Moderate to High KDPI Transplants?
J. Foutz, R. J. Carrico, K. Sisaithong, H. Tosoc-Haskell, D. Klassen
Research, United Network for Organ Sharing, Richmond, VA
*Purpose: The Collaborative Innovation and Improvement Network (COIIN) was a 3-year OPTN project aimed at increasing the utilization of kidneys with a kidney donor profile…
2019 American Transplant Congress
Risk Factors for 1-5 Year De Novo Cancers after Kidney Transplant (KTx) with First-Year Immunosuppression (IS) Data: An Analysis of the Choosing Immune Suppression by Efficacy and Morbidity (CISTEM) Study
V. Dharnidharka¹, D. Axelrod², Z. Zhang³, M. Schnitzler³, K. Lentine³, B. Kasiske⁴
¹Washington Univ, St. Louis, MO, ²Univ of Iowa, Iowa City, IA, ³Saint Louis Univ, St. Louis, MO, ⁴SRTR, Minneapolis, MN
*Purpose: From our CISTEM study of linked national registries, we published data on risk factors for within-3-years post-KTx non-melanoma skin cancer (NMSC) and viral-driven cancers…